US Patent 10308934 Compositions for modulating Ataxin 2 expression
Patent 10308934 was granted and assigned to Ionis Pharmaceuticals on June, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10308934 Compositions for modulating Ataxin 2 expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
